TGA Approval

HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe (385133)

ARTG ID

385133

ARTG Name

HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe

Sponsor

Samsung Bioepis AU Pty Ltd

ARTG Date

February 15, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Samsung Bioepis AU Pty Ltd

https://medical-cdn.nocode.com/drug_tga/afa317378f098952ceea306e1b093db9.pdf

https://medical-cdn.nocode.com/drug_tga/3a2a0570999fd6263752c1061f3099f4.pdf

Ingredient Name

Adalimumab

Empowering clinical research with data-driven insights and AI-powered tools.

HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe (385133) - TGA 批准文号 | MedPath